Ventilator-associated pneumonia (VAP) remains a morbid and prevalent problem throughout the world. Lung ultrasound (LUS) is increasingly being used at the bedside for assessing alveolar-interstitial syndrome, lung consolidation, pneumothorax, and pleural effusion.
Introduction
Many advantages of lung sonography, both therapeutic and diagnostic, have been established [1] . Although chest radiography (CXR) and computed tomography (CT) are still considered the main techniques for evaluating the chest, ultrasound (US) had definite and useful role in certain circumstances. In particular, US is most useful in remote intensive care situation where patients are often too ill [2] . Clinical applications for lung ultrasound (LUS) included assessment of pleural disorders, lung parenchymal diseases, and diaphragmatic dysfunctions. The main advantage of LUS is the lack of the ionizing radiations, which makes LUS a good method of diagnosis and follow-up [3] . One of the established complications that occur in the ICU is ventilator-associated pneumonia (VAP), which occurs in mechanically ventilated (MV) patients. VAP is associated with 10% inpatient mortality, with more than three million deaths per year. To avoid this major complication during patient's admission, an early-onset diagnosis and intervention associated with close follow-up are needed [4] . An easy and accurate imaging modality is needed to confirm a rapid diagnosis and early intervention. Studies found only 75% accuracy of CXR when compared with CT [5, 6] . The routine use of CT is limited by radiation exposure, need for patient transport, and cost [7] . The use of LUS in early management of VAP is an exciting and powerful recent development in clinical medicine [8] . The key to US visualization of pneumonia in lung is relative loss of the aeration of apportion of the lung and a concomitant increase in the fluid content. When the pathological process extends to the pleura, it can be detected with LUS. On standard US examination, lung consolidation from pneumonia is often described as having tissue-like pattern and is referred to as hepatization to illustrate its gray-scale density and general appearance. The segments or lobes of the lung being affected by the pneumonic process are defined by pleural line, the adjacent normal lung tissues, and any pleural effusion that may be present [9] . A dendrite-like air bronchogram and large number of scatter artefacts from air are frequently traceable up to the pleura. In real time, air can be seen moving through bronchi, and this finding is known as a dynamic air bronchogram. The most common US findings associated with pneumonia are hypoechoic areas of varying size and shape, irregular and serrated margins, heterogeneous echotexture, air bronchogram, dynamic air bronchogram, pleural effusion, vascular flow in consolidated lung on color or power Doppler imaging, and tissue sign in which the lung tissue appears like hepatic tissues [9] . US can help determine the nature of the associated effusion. Based on the internal echogenicity, an effusion can be classified as anechoic, complex nonseptated, complex septated, and homogeneously echogenic. The importance of LUS as an effective method for assessment of the presence, amount, and nature of pleural effusions was established. LUS can identify trace effusions missed by CXR and can help determine if an elevated hemidiaphragm is because of a subpulmonic or subphrenic collection or diaphragmatic paralysis [9] . Grading of pleural effusion regarding its nature is an excellent way for the diagnosis of it, as anechoic effusions can be either transudates or exudates; homogeneously echogenic effusions are usually seen in empyema or hemorrhage, as the echogenic material is usually because of debris, protein-rich elements, or blood [10] . LUS is a simple, an easy, cheap, and accurate imaging technique, especially without the ionizing radiation [11] .
Patients and methods
A prospective cohort study was conducted on 40 suspected ventilator-associated pneumonia (VAP) cases recruited from Pulmonary Critical Care Unit, Menoufia University Hospital, during the period from June 2016 to September 2017. This study was approved by the research ethics committee, and a written consent was obtained from patient's relatives before the beginning of this work. Patients were enrolled within 24 h of the point at which criteria were met for suspected VAP. On enrollment, the following variables were recorded: demographics (height, weight, and comorbidities), ventilation parameters, infectious disease data during present admission (antibiotic history and culture data), and biochemical data (white blood cells count with differential, erythrocyte sedimentation rate, and arterial blood gas). Microbiological data, radiological data (portable CXR and CT chest), and clinical pulmonary infection score (CPIS) were also calculated. Primary outcome measures were VAP diagnosis based on positive microbiological data from tracheal aspirate, deep bronchial suctioning, or bronchoscopic lavage, along with new infiltrates on CXR, and presence of clinical signs of pulmonary infection or systemic inflammation. CPIS was also used for assessment (a score of 6 is suggestive of VAP) [12] . CPIS included the following: temperature 38.5-38.9°C=1 point, greater than or equal to 39 or less than 36.5°C=2 points, white blood cells less than 4000 or greater than 11 000/ mm 3 =1 point, nonpurulent respiratory secretions=1 point, purulent respiratory secretions=2 points, CXR diffuse infiltrate=1 point, localized infiltrate=2 points, progressive infiltrate (without cardiac disease or ARDS)=2 points, moderate or heavy microbiologic quantitative or heavy microbiologic quantitative-positive=1 point, microbiologic quantitative-positive and same pathogenic bacteria seen on Gram stain=2 points, and PaO 2 /FiO 2 less than or equal to 240 without ARDS=2 points [12] . Secondary outcome measures included sensitivity, specificity, and diagnostic accuracy of LUS alone and in association with the CPIS for early diagnosis of VAP. CT scans were performed as gold standard of diagnosis. LUS was performed using digital US imaging system model (Philips, Holland) with macro convex probe 2-5 MHz. LUS includes examination of both lungs. Each hemithorax will be divided into three regions using parasternal, anterior, and posterior axillary lines as landmarks. Each of these regions will be further divided into upper and lower quadrants, yielding a total of six quadrants per hemithorax [12] . The LUS finding was positive and patients were diagnosed with VAP if they had characteristics of pneumonia on LUS, including breath-dependent motion of consolidation, visible air bronchograms, and basilar pleural effusions. Examination will specifically identify the presence or absence of normal pleural A lines, noncoalescent B lines, and coalescent B lines. Characteristics of pleural effusions (parapneumonic or empyema) on LUS revealed that pleural effusions with an appearance other than anechoic were exudates; anechoic effusions can be either transudates or exudates. Homogeneously echogenic effusions were seen in empyema. The patient's status (outcome) was documented (improved vs. died).
Results
A prospective cohort study was performed on 40 VAPsuspected cases, their mean age was 46.63±15.26 years and ranged from 19 to 73 year. Overall, 46.7% were males, 26.7% were smokers, 93.3% experienced fever, and 40% had PaO 2 /FiO 2 less than or equal to 240 ( (Table 4 ). Low CPIS less than or equal to 6, lower body temperature, modes of MV (CPAP and BIPAP), shorter duration of respiratory support, LUS imaging of air bronchogram, and simple pleural effusion were significantly associated with improved outcomes of VAP cases ( Table 5 ). Binary logistic regression analysis for independent risk predictors for mortality of VAP patients revealed that duration of MV and detection of air bronchogram by US were the independent mortality predictors with odds ratio of 2.4 and 3.11, respectively, and 95% CI of 1.56-4.55 and 1.8-17.66, respectively ( Table 5 ).
Discussion
VAP is defined as any evidence of a new infection that occurs at least 48 h after the onset of MV [13] . The uncertainties regarding the most appropriate diagnostic method to identify VAP compromise the management of this condition. US is a noninvasive, easily repeatable, and bedside means to assess VAP [14] . This study highlighted that the diagnostic accuracy of LUS alone (93.3%) was better than CXR, which demonstrate sensitivity of 86.7%, and the lowest sensitivity was for CIPS (50%). When associating LUS with the CPIS for VAP diagnosis, the sensitivity elevated up to 97.3%. Similar results was observed by Yang et al. [15] who postulated that LUS exhibited a pooled sensitivity of 0.904 (0.884-0.921), specificity 0.884 (0.861-0.904), and area under the curve of 0.9611, and when comparing the diagnostic efficiency of LUS for pneumonia in adult with CXR, the area under the curve for LUS and CXR was 0.972 and 0.867, respectively. A study of Shan et al. [16] documented sensitivity and specificity for CPIS were 65 and 64%, respectively. The current work also determined the frequency of specific LUS signs (subpleural consolidation, irregular B lines, air bronchogram) and confirmed that air bronchogram sign (an early sign of pneumonia) was obviously detectable in LUS than other imaging techniques, even CT, which in turn indicate early detection of VAP and significantly associated with better outcome. Moreover, the present work is in agreement with that of Berlet et al. [17] who performed daily LUS in MV patients and proved the importance of LUS in early diagnosis and early management of VAP. The presence of consolidation with air bronchogram sign either static or dynamic had 100% sensitivity and 60% specificity for diagnosis of VAP. The vascular pattern within the consolidation, as assessed by color Doppler US, provides an alternative means for determining the etiology of pulmonary consolidations. Lichtenstein et al. [18] , who considered CT as the gold standard in diagnosing VAP, found that the sensitivity and specificity of LUS in the diagnosis of VAP were 90 and 98%, respectively. Bouhemad et al. [19] reviewed nine studies that assessed LUS and demonstrated a mean sensitivity of 97% with a specificity of 94% for LUS in diagnosis of VAP. Beckh et al. [20] included five studies; using the hospital diagnosis as the standard, they calculated a pooled sensitivity of 95% for LUS compared with 77% for CXR. In addition, they detected a higher accuracy for LUS than CXR with CT as the gold standard. A study by Nazerian et al.
[21] compared LUS with CT in the detection of consolidations and in keeping with other studies found a sensitivity of 83%. LUS has been found to be cost effective besides its diagnostic value in a study by Testa et al. [22] which supported the implementation of US in a department of medicine from the financial perspective. The value of our imaging technique for detection of pleural effusion was as follows: radiographic study revealed sensitivity of 35.7%, specificity of 100%, and accuracy of 77.5%, whereas US revealed 92.9%, 100%, and 97.5% for sensitivity, specificity, and accuracy, respectively; LUS demonstrate extra advantages of detecting simple and complicated effusion. These findings were supported by Gleeson and Qureshi [23] and Froudarakis [24] who documented the accuracy of LUS to detect as little pleural fluid as 5-50 ml with its ability to detect different grades of pleural effusion. In addition to its excellent diagnostic potential, LUS has advantages, such as high learn ability, good diagnostic agreement, and reduced radiation exposure. The degree of interpretation with LUS is subjective than with CXR especially in MV patients [25] [26] [27] . CXR usually has falsenegative results in cases of early stages of pneumonia, supine views, or when lesions are in hidden areas of CXR. Moreover, CXR cannot precisely detect lung consolidations of less than 1 cm. The outcome of radiological findings requires degree of interpretation present during radiological assessment, which requires sometimes repeating the imaging modality. Repeated CXR could overexpose some critically ill patients in the ICU to radiation. Despite its use as the gold standard in diagnosis of many chest disorders including the diagnosis of pneumonia, CT imaging cannot be routinely used in all patients suspected of pneumonia owing to its higher radiation exposure, the requirement of more medical assistance, and the difficulty of transportation, especially MV patients. All the previous limitations were overcomed with the use of bedside LUS, which led to a 26% reduction in CXR and a 47% reduction in CT scans in the ICU [28] [29] [30] .
Limitation of lung ultrasound in ventilator-associated pneumonia LUS may not be suitable for obese, noncooperative patients, and those with thoracic dressings, a drainage A 57-year-old male patient is presented. Her chest radiography showed bilateral heterogeneous opacities. Mediastinal and pulmonary windows of computed tomography showed opacities with air bronchogram. Lung ultrasound confirmed consolidative hypoechoic area with air bronchogram.
Figure 1
A 73-year-old male smoker is presented. His chest radiography showed obliteration of right cost phrenic angle with semi-homogenous opacity at right lower zone. Mediastinal and pulmonary windows of computed tomography showed homogenous opacity at post segment of right lower lobe and rim of pleural effusion. Lung ultrasound showed hypoechoic area with air bronchogram and anechoic pleural effusion.
tube, or pleural calcifications. In addition, some normal anatomic structures (clavicle and scapula) act like a shield that hinder the lung and make approximately 20% of its surface not visualized by LUS [30, 31] . Lesion size and distance between the lesion and lung surface influence the detection efficiency of LUS for VAP. When the size of the lesion is less than 20 mm, deeply located in lung tissues, and posteriorly located, it may not be detected by LUS [32, 33] . Adequate training among clinicians is needed. Furthermore, LUS cannot be considered disease specific. Clinical and investigational examinations should be always present to give a conclusive LUS report. CT, computed tomography; CX, chest radiography; LUS, lung ultrasound; VAP, ventilator-associated pneumonia. 
Conclusion
Bedside thoracic US can be an invaluable tool in early diagnosis of VAP. Our study indicated that LUS is a robust diagnostic tool for VAP with high accuracy. Its ability to provide real-time, low-cost, rapid images allows it to complement the use of clinical signs and symptoms in bedside diagnosis and management of VAP. It may be of particular value in areas with limited access to traditional diagnostic radiology and as a technique to limit exposure to ionizing radiation. Image acquisition and interpretation can readily be taught to learners of varied experience. LUS repeatedly outperforms CXR and has key advantages over chest CT.
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